Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × cobimetinib × Dermatologic × Clear all

Phase

Status

Completed 15 Terminated 8 Active not recruiting 4 Recruiting 2 Withdrawn 1 Unknown 1 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

pembrolizumab 2 talimogene laherparepvec 1 sargramostim 1 romiplostim 1 imisopasem manganese 1 gusacitinib 1 dabrafenib 1 cobimetinib 1 Propranolol 1 Paclitaxel 1 ON 01910 1 Microscopy, Confocal 1 Magnetic Resonance Spectroscopy 1 Drug Therapy 1 Curettage 1 CA-4948 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05756556 2024-02-01

T3011 in Combination With Cobimetinib in Patients With Advanced Melanoma

ImmVira Pharma Co. Ltd

Phase 2 Suspended

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡